Global Markets

AstraZeneca (AZN LN) EMA's CHMP adopted a positive opinion recommending a change to the terms of the marketing authorisation for AstraZeneca's Leqvio

1 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more